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Table 3. Predictors of cerebrovascular disease, cardiovascular disease or both (CVD) in non-GCA and GCA cohorts, six independent analyses (SHR 95% CI)  
  Cerebrovascular disease   Cardiovascular disease   





















     65 to less than 70 1.81 (1.51, 2.16)*** 1.96 (1.40, 2.75)*** 
 
1.75 (1.55, 1.98)*** 1.34 (1.04, 1.73)* 
 
1.76 (1.58, 1.95)*** 1.61 (1.31, 1.99)*** 
     70 to less than 75 2.89 (2.47, 3.37)*** 2.22 (1.63, 3.02)*** 
 
1.82 (1.62, 2.05)*** 1.44 (1.14, 1.82)** 
 
2.18 (1.98, 2.40)*** 1.74 (1.43, 2.10)*** 
     75 to less than 80 3.50 (2.99, 4.09)*** 2.57 (1.88, 3.53)*** 
 
1.96 (1.74, 2.21)*** 1.57 (1.23, 1.99)*** 
 
2.47 (2.24, 2.72)*** 1.82 (1.49, 2.23)*** 
     80 and above 4.18 (3.58, 4.86)*** 3.20 (2.36, 4.35)*** 
 
1.58 (1.40, 1.79)*** 1.44 (1.12, 1.84)** 
 
2.45 (2.23, 2.70)*** 1.98 (1.62, 2.42)*** 
Gender  





    male 1.09 (0.98, 1.20) 1.03 (0.84, 1.27) 
 
1.52 (1.40, 1.64)*** 1.32 (1.12, 1.56)** 
 
1.34 (1.25, 1.43)*** 1.20 (1.05, 1.38)** 
BMI categories 
             underweight 0.95 (0.74, 1.21) 1.09 (0.54, 2.20) 
 
0.95 (0.68, 1.31) 1.16 (0.66, 2.07) 
 
0.95 (0.77, 1.18) 1.17 (0.78, 1.77) 





     pre-obese 1.02 (0.90, 1.15) 1.19 (0.94, 1.50) 
 
1.07 (0.98, 1.18) 1.10 (0.90, 1.35) 
 
1.05 (0.97, 1.14) 1.10 (0.93, 1.30) 
     obese class 1&2 1.13 (0.98, 1.31) 0.98 (0.72, 1.35) 
 
1.08 (0.96, 1.22) 1.34 (1.06, 1.70)* 
 
1.11 (1.00, 1.22)* 1.20 (0.99, 1.46) 
     obese class 3 0.99 (0.62, 1.58) 1.24 (0.53, 2.89) 
 
0.97 (0.68, 1.38) 1.57 (0.89, 2.78) 
 
1.02 (0.76, 1.36) 1.51 (0.94, 2.43) 
Smoking  





     ex 1.05 (0.93, 1.18) 0.98 (0.78, 1.24) 
 
1.03 (0.94, 1.14) 1.06 (0.87, 1.29) 
 
1.03 (0.95, 1.11) 1.01 (0.86, 1.19) 
     yes 1.20 (1.04, 1.39)* 1.25 (0.96, 1.64) 
 
1.15 (1.03, 1.27)* 1.08 (0.85, 1.36) 
 
1.18 (1.08, 1.29)*** 1.13 (0.95, 1.34) 
Alcohol  





     ex 0.97 (0.76, 1.23) 1.21 (0.77, 1.89) 
 
0.86 (0.69, 1.06) 0.88 (0.60, 1.28) 
 
0.88 (0.74, 1.04) 1.02 (0.77, 1.34) 
     yes 1.00 (0.89, 1.13) 0.87 (0.65, 1.16) 
 
0.93 (0.83, 1.03) 0.87 (0.71, 1.06) 
 
0.95 (0.88, 1.03) 0.87 (0.73, 1.03) 
IMD Quintiles   





     quintile 2 0.96 (0.82, 1.13) 0.97 (0.66, 1.43) 
 
1.10 (0.97, 1.25) 1.00 (0.76, 1.32) 
 
1.06 (0.96, 1.18) 1.01 (0.81, 1.27) 
     quintile 3 1.05 (0.88, 1.26) 1.15 (0.80, 1.63) 
 
1.09 (0.94, 1.26) 1.10 (0.81, 1.50) 
 
1.11 (0.98, 1.26) 1.13 (0.90, 1.42) 
     quintile 4 1.10 (0.92, 1.33) 0.98 (0.66, 1.47) 
 
1.25 (1.09, 1.44)** 1.22 (0.89, 1.66) 
 
1.22 (1.10, 1.36)*** 1.16 (0.91, 1.47) 
     quintile 5 (most deprived) 1.03 (0.86, 1.23) 1.31 (0.91, 1.90) 
 
1.32 (1.12, 1.55)** 1.24 (0.86, 1.79) 
 
1.21 (1.08, 1.37)** 1.34 (1.01, 1.78)* 
Previous history of hyperlipidaemia 0.84 (0.62, 1.13) 1.40 (0.90, 2.17) 
 
1.28 (1.06, 1.54)** 1.08 (0.74, 1.58) 
 
1.12 (0.95, 1.32) 1.17 (0.85, 1.59) 
Previous history of hypertension 1.53 (1.29, 1.80)*** 0.74 (0.49, 1.12) 
 
1.84 (1.59, 2.13)*** 1.53 (1.14, 2.05)** 
 
1.78 (1.59, 1.99)*** 1.15 (0.90, 1.48) 
Previous prescription of anti-hypertensives 0.70 (0.58, 0.84)*** 1.31 (0.84, 2.05) 
 
0.75 (0.64, 0.88)*** 0.77 (0.56, 1.06) 
 
0.69 (0.61, 0.79)*** 0.97 (0.74, 1.27) 
Previous history of diabetes or diabetic 
medications  1.28 (1.10, 1.50)** 1.29 (0.94, 1.78) 
 
1.14 (1.00, 1.30)* 1.12 (0.86, 1.45) 
 
1.22 (1.10, 1.36)*** 1.19 (0.96, 1.47) 
Previous prescription of lipid-lowering 
medications  0.76 (0.63, 0.93)** 0.87 (0.61, 1.24) 
 
1.14 (1.00, 1.31)* 1.20 (0.92, 1.58) 
 
1.00 (0.89, 1.12) 1.08 (0.86, 1.35) 
*p-value<0.05, **p-value<0.01, ***p-value<0.001 
Multivariable competing risk model (imputed) inclusive of all listed covariates and adjusted for covariate interaction (hypertension and anti-hypertensives, hypertension and lipid-lowering medications, hypertension 
and hyperlipidaemia) 
Significant interactions p<0.05 - Cerebrovascular disease non-GCA: hypertension and anti-hypertensives, hypertension and hyperlipidaemia; Cerebrovascular disease GCA: none; Cardiovascular disease non-GCA: 
hypertension and anti-hypertensives; Cardiovascular disease GCA: hypertension and anti-hypertensives; Cerebrovascular disease or cardiovascular disease non-GCA: hypertension and anti-hypertensives, hypertension 
and hyperlipidaemia; Cerebrovascular disease or cardiovascular disease GCA: hypertension and anti-hypertensives 
